Multiple roles of HDAC inhibition in neurodegenerative conditions

DM Chuang, Y Leng, Z Marinova, HJ Kim… - Trends in neurosciences, 2009 - cell.com
Histone deacetylases (HDACs) play a key role in homeostasis of protein acetylation in
histones and other proteins and in regulating fundamental cellular activities such as …

Histone deacetylase inhibitors

TA Miller, DJ Witter, S Belvedere - Journal of medicinal chemistry, 2003 - ACS Publications
Histone deacetylase enzymes, which have been divided into three distinct structural classes,
operate by zinc-dependent (class I/II) or NAD-dependent (class III) mechanisms. Class I/II …

Distribution of histone deacetylases 1–11 in the rat brain

RS Broide, JM Redwine, N Aftahi, W Young… - Journal of Molecular …, 2007 - Springer
Although protein phosphorylation has been characterized more extensively, modulation of
the acetylation state of signaling molecules is now being recognized as a key means of …

Epigenetic targeting of histone deacetylase: therapeutic potential in Parkinson's disease?

IF Harrison, DT Dexter - Pharmacology & therapeutics, 2013 - Elsevier
Parkinson's disease (PD) is the most common movement disorder affecting more than 4
million people worldwide. The primary motor symptoms of the disease are due to …

Valproic acid reduces brain damage induced by transient focal cerebral ischemia in rats: potential roles of histone deacetylase inhibition and heat shock protein …

M Ren, Y Leng, MR Jeong, PR Leeds… - Journal of …, 2004 - Wiley Online Library
Growing evidence from in vitro studies supports that valproic acid (VPA), an anti‐convulsant
and mood‐stabilizing drug, has neuroprotective effects. The present study investigated …

Histone deacetylase inhibitors up-regulate astrocyte GDNF and BDNF gene transcription and protect dopaminergic neurons

X Wu, PS Chen, S Dallas, B Wilson… - International Journal …, 2008 - academic.oup.com
Parkinson's disease (PD) is characterized by the selective and progressive loss of
dopaminergic (DA) neurons in the midbrain substantia nigra. Currently, available treatment …

Mood stabilizer valproate promotes ERK pathway-dependent cortical neuronal growth and neurogenesis

Y Hao, T Creson, L Zhang, P Li, F Du… - Journal of …, 2004 - Soc Neuroscience
Manic-depressive illness has been conceptualized as a neurochemical illness. However,
brain imaging and postmortem studies reveal gray-matter reductions, as well as neuronal …

Regulation of microglial inflammatory response by sodium butyrate and short‐chain fatty acids

J Huuskonen, T Suuronen, T Nuutinen… - British journal of …, 2004 - Wiley Online Library
Recent studies have shown that sodium butyrate and other short‐chain fatty acids (SCFAs)
can prevent inflammation in colon diseases. Our aim was to elucidate whether sodium …

Biochemical, molecular and epigenetic mechanisms of valproic acid neuroprotection

B Monti, E Polazzi… - Current molecular …, 2009 - ingentaconnect.com
Valproic acid (VPA, 2-propylpentanoic acid) has been widely used as an antiepileptic drug
and for the therapy of bipolar disorders for several years. Its mechanism of action was …

Valproic acid and other histone deacetylase inhibitors induce microglial apoptosis and attenuate lipopolysaccharide-induced dopaminergic neurotoxicity

PS Chen, CC Wang, CD Bortner, GS Peng, X Wu… - Neuroscience, 2007 - Elsevier
Valproic acid (VPA), a widely prescribed drug for seizures and bipolar disorder, has been
shown to be an inhibitor of histone deacetylase (HDAC). Our previous study has …